Find Academic Supervisors

Michael Yeager, PhD, serves as an Associate Clinical Professor in the School of Medicine at the University of Colorado Denver, focusing on cardiopulmonary pathophysiology with emphasis on pulmonary hypertension and heart failure mechanisms. He completed his PhD at the University of Colorado Health Sciences Center in 2002, establishing foundational expertise in vascular biology. His research program investigates immunological and molecular drivers of pulmonary vascular disease, particularly the roles of autoantibodies, fibrocytes, and inflammatory cascades in disease progression. Analysis of his 14 publications (2012-2015) reveals consistent exploration of biomarker discovery, vascular remodeling, and immune dysregulation across pediatric and adult pulmonary hypertension. Key methodological approaches include proteomics, animal modeling, and molecular interrogation of cellular stress responses, with significant translational implications for personalized therapeutic strategies. Professional recognitions include: Outstanding Faculty award from Tau Beta Pi (2019) Chancellor's Teaching Recognition Award from the University of Colorado (2016) Dr. Yeager maintains active clinical research collaborations at Children's Hospital Colorado while mentoring within the medical school curriculum. His work bridges basic science discovery with clinical application through ongoing investigations into endothelial dysfunction and inflammatory mediators. Affiliated with the Department of Medicine, he contributes to pulmonary vascular research initiatives and participates in professional societies including the American Thoracic Society, American Heart Association, and T21 Research Society.

• Pulmonary vasculature
• Heart Failure
• Cardiopulmonary Immunology

Jennifer A. Smith, PhD, MPH is an Associate Professor of Epidemiology and Research Associate Professor of Survey Research at the University of Michigan School of Public Health . She also serves as Director of the Certificate in Public Health Genetics and is Assistant Director of the Cohort Development working group for U-M Precision Health and the Michigan Genomics Initiative. Education: PhD, Epidemiology, University of Michigan (2011) MA, Statistics, University of Michigan (2009) MPH, Health Management and Policy, University of Michigan (2005) BS, Biological Sciences, Cornell University (2001) Research Interests: Dr. Smith is a genetic epidemiologist whose work lies at the intersection of genomics, epigenomics, and social epidemiology . She investigates how genetic, epigenetic, and transcriptomic variation influence age-related chronic diseases such as cardiovascular disease, hypertension, dementia, and cognitive decline. A major focus is understanding how social, psychosocial, and neighborhood determinants interact with genetic risk to shape socioeconomic and racial/ethnic health disparities . Research Projects: Her work leverages large, multi-ethnic cohorts including the Health and Retirement Study (HRS), GENOA, SWAN, MESA, and LASI. She is a core faculty member of the Center for Social Epidemiology and Population Health (CSEPH) , and affiliated with MiCDA, the Center for Midlife Science, and the PNG Program . She also collaborates with leading consortia such as CHARGE and TOPMed. Selected Trends in Publications: Her recent work (2022–2025) emphasizes epigenetic mediation of social determinants on cardiovascular and cognitive health, polygenic risk scores across diverse ancestries , and multi-omics integration in aging and disease. These studies consistently highlight how social environments and genetic architecture jointly influence health outcomes across populations. Contact: Email: smjenn@umich.edu Office: 734-615-9455 Address: 2631 SPH I, 1415 Washington Heights, Ann Arbor, MI 48109

• Genetic Epidemiology
• Epigenomics
• Aging
• +4 more

Vitaly Kheyfets, PhD, serves as Associate Professor in the Department of Pediatrics-Critical Care Medicine at the University of Colorado Anschutz Medical Campus School of Medicine, where he directs research at the intersection of pediatric critical care and cardiopulmonary pathophysiology with emphasis on pulmonary arterial hypertension (PAH). His primary research focuses on right ventricular adaptation to pulmonary hypertension, utilizing machine learning-driven multi-omics analysis to identify disease biomarkers and molecular networks. He pioneers computational fluid dynamics approaches for hemodynamic modeling in congenital heart conditions like Glenn physiology, while also investigating sleep oscillatory patterns as neurodegenerative biomarkers. His methodology integrates proteomics, spatial transcriptomics, and pressure waveform analysis to dissect vascular remodeling mechanisms. Publication trends reveal a strong emphasis on translating computational models into clinical applications for PAH prognostication, with recent work developing AI-cooperative diagnostic platforms and characterizing microvascular changes in the right ventricle. Cross-disciplinary collaborations span proteomics, imaging, and sleep neuroscience, demonstrating consistent innovation in both pulmonary hypertension and neurodegenerative disease biomarker discovery.

• Pulmonary Arterial Hypertension
• Critical Care Medicine
• Pediatric Cardiology
• +4 more

Lloyd D. Petty, DO, MPH, is a Clinical Assistant Professor in the Department of Internal Medicine at the University of Utah School of Medicine. He specializes in Endocrinology, Diabetes & Metabolism, providing clinical care while contributing to academic research. Education: D.O. and M.P.H. from Nova Southeastern University College of Osteopathic Medicine; B.S. in Physiology from University of Arizona Training: Chief Residency at University of New Mexico School of Medicine; Fellowship in Endocrinology at University of Utah School of Medicine His research focuses on endocrine disorders, particularly diabetes, osteoporosis, and thyroid diseases. Recent publications explore hormonal-gastrointestinal interactions, bone health in oncology patients, and minimally invasive endocrine procedures. Key publications span bone metabolism in chronic lymphocytic leukemia (2024), adrenal gland ablation techniques (2022), and endocrine-gastrointestinal case studies (2017-2023). The work demonstrates expertise in clinical endocrinology applications.

• Endocrinology
• Diabetes
• Osteoporosis
• +3 more

Matthew Beutner, MD is an Assistant Clinical Professor at the University of California, San Francisco (UCSF) School of Medicine. He serves as Director of the Pulmonary Hypertension Program and Pulmonary Rehabilitation Program. His clinical expertise lies in Pulmonary and Critical Care Medicine, with specialization in Pulmonary Hypertension and Interstitial Lung Disease. Dr. Beutner completed his BS in Health Sciences at Saint Mary's College of California (2011), MD at Ross University School of Medicine (2015), residency in Internal Medicine at UCSF Fresno (2019), and fellowship in Pulmonary and Critical Care Medicine at UCSF Fresno (2022). His research focuses on therapeutic interventions for pulmonary hypertension, as evidenced by his 2020 case series on riociguat in chronic thromboembolic pulmonary hypertension. No awards or grants are explicitly listed, though his leadership roles reflect professional recognition. His advisory activities and lab/team affiliations are not detailed in the provided materials.

• Pulmonary Medicine
• Critical Care Medicine
• Pulmonary Hypertension
• +2 more

Zachi Attia, Ph.D., M.B.A., is an Associate Professor at the Mayo Clinic College of Medicine and Science, Rochester, Minnesota. His research focuses on applying artificial intelligence (AI) and machine learning to cardiac biosignals, particularly for early disease detection and prediction. He holds primary and joint appointments as Consultant in AI within the Department of Cardiovascular Medicine, collaborating with the Center for Digital Health and the Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery. Education: Ph.D. in Electrical Engineering from the University of Minnesota, Rochester; BSc and MSc in Electrical Engineering from Ben Gurion University, Israel. Dr. Attia's work centers on developing AI models that analyze multimodal cardiac data (ECGs, echocardiograms, angiograms) to detect silent diseases. His research includes pragmatic clinical trials to validate AI's impact on patient outcomes, explainable AI for biological insights, and integrating AI dashboards into medical records for clinical usability. Recent publications highlight AI applications in detecting atrial fibrillation, hypertrophic cardiomyopathy, and pulmonary hypertension via ECG analysis. Scientific Awards: No explicit awards mentioned in the text. Email: attia.itzhak@mayo.edu

• Artificial Intelligence
• Machine Learning
• Signal Processing
• +4 more

Karima Addetia serves as an Associate Professor in the Department of Medicine-Cardiology at the University of Chicago. Her academic career has been dedicated to advancing echocardiographic techniques and their clinical applications, particularly in the assessment of right heart function, cardiac amyloidosis, and tricuspid valve pathology. She has established herself as a leading researcher in cardiac imaging through extensive collaborations with the World Alliance of Societies of Echocardiography (WASE) and frequent co-authorship with Dr. Roberto M. Lang, a prominent figure in cardiovascular imaging. Dr. Addetia's research interests span multiple critical areas in cardiovascular medicine. She has pioneered work in right heart assessment, establishing normative values for right ventricular size and function through large-scale multicenter studies. Her investigations into cardiac amyloidosis have significantly advanced the understanding of echocardiographic patterns associated with this condition, particularly regarding apical sparing and strain patterns. She has also made substantial contributions to tricuspid valve assessment, examining both normal anatomy and pathological conditions including device-related complications. More recently, her work has incorporated artificial intelligence applications in echocardiography, exploring how machine learning can improve diagnostic accuracy and workflow efficiency. The trajectory of Dr. Addetia's research publications reveals a consistent focus on quantitative cardiac imaging with increasing sophistication over time. Her early work established foundational knowledge about right ventricular morphology and function, while more recent publications integrate advanced technologies like AI and focus on specific disease states like cardiac amyloidosis. A notable pattern is her participation in large, collaborative studies that establish normative values across diverse populations, addressing important gaps in understanding how cardiac measurements vary by age, sex, and ethnicity. Her work consistently bridges technical echocardiographic advancements with direct clinical applications. Dr. Addetia's collaborative approach is evident through her extensive involvement with the WASE study group and numerous multicenter investigations. Her research methodology typically combines rigorous quantitative analysis with clinical correlation, producing findings that directly impact diagnostic criteria and clinical practice guidelines. While specific grant information isn't detailed in the available publications, her leadership in major collaborative studies suggests significant research funding support for her work in cardiac imaging innovation.

• Echocardiography
• Cardiac Imaging
• Right Heart Function
• +5 more

James Corbett serves as Professor of Radiology and Professor of Internal Medicine at the University of Michigan Medical School, with dual appointments reflecting his interdisciplinary expertise. He is an active Center Member of the Samuel and Jean Frankel Cardiovascular Center, contributing to one of the nation's leading cardiovascular research and clinical care institutions. Professor Corbett's research program centers on nuclear cardiology innovation, particularly PET-based myocardial blood flow quantification. His work bridges technical imaging optimization (e.g., Rb-82 dosing protocols, temporal sampling methods) with clinical applications in arrhythmia risk assessment, diastolic dysfunction, and pulmonary hypertension management. He has significantly influenced global standards through leadership in the IAEA Nuclear Cardiology Protocols Study (INCAPS) and SNMMI/ASNC clinical guidelines. His publication record from 2016-2019 reveals a strategic focus on advancing quantitative cardiac imaging while addressing real-world clinical challenges. The research demonstrates consistent methodology development paired with outcome studies, often through large multi-center collaborations that enhance generalizability of findings. As an active mentor (explicitly noted in his profile), Professor Corbett guides trainees through the University of Michigan's robust medical education system. His involvement in major international studies indicates substantial grant funding history, though current specific awards aren't detailed in the provided materials. The Samuel and Jean Frankel Cardiovascular Center affiliation provides Professor Corbett's team with state-of-the-art imaging facilities and access to diverse cardiovascular patient populations, enabling translational research from technical innovation to clinical implementation.

• Cardiology
• Nuclear Medicine
• Cardiovascular Imaging
• +2 more

Russell Richardson is a tenured Professor at the University of Utah , holding joint appointments in the Department of Internal Medicine (Division of Geriatrics) and the Department of Exercise and Sport Science . He directs the Utah Vascular Research Laboratory (UVRL) at the Salt Lake VA Medical Center. Education: Fellowship (University of California San Diego), Doctoral Training (University of Utah), PhD (Colorado State University), MS (Loughborough University), PGCE (West London Institute of Higher Education) His research focuses on oxygen transport from air to tissue , with a current emphasis on the link between vascular and skeletal muscle function , particularly how oxidative stress regulates skeletal muscle metabolism and vascular control. He has authored numerous studies on aging, vascular dysfunction, and exercise hemodynamics. Recent publications highlight work on mitochondrial respiration, passive limb movement techniques, antioxidant interventions, and age-related vascular decline. His lab employs both in vivo and ex vivo methodologies to investigate these mechanisms. Collaborations span clinical and physiological domains, including studies in chronic obstructive pulmonary disease (COPD), heart failure, and breast cancer. His work integrates gerontology , exercise physiology , and vascular biology . Notable affiliations include the Salt Lake VA Medical Center and contributions to understanding the interplay between physical activity, aging, and vascular plasticity.

• Oxygen Transport
• Vascular Physiology
• Skeletal Muscle Metabolism
• +3 more

Craig Morrell is a Professor at the University of Rochester School of Medicine and Dentistry , with joint appointments in the Departments of Medicine , Microbiology and Immunology , and Pathology and Laboratory Medicine . He serves as Associate Director of the Aab Cardiovascular Research Institute . Education: Sc.B. in Biology, Brown University (1995) D.V.M. , Tufts University School of Veterinary Medicine (2000) Ph.D. in Pathobiology, Johns Hopkins University (2005) His research examines the interface between platelets, vascular biology, and immune cells , focusing on platelet roles in thrombosis, inflammation, and immune regulation. Using advanced mouse models , his lab investigates platelet-derived mediators like β2M and PF4 in diseases such as malaria, stroke, and myocardial infarction. Article trends highlight platelets' dual roles in thrombosis and immune modulation , with recurring themes in vascular inflammation , ERK5 signaling , and age-related immune dysfunction . Scientific Awards: Kenneth M. Brinkous Young Investigators Prize (2008) Deans Gift research award (2006) Multiple travel scholarships and fellowships (2003-2005) Pathology Award-Excellence in Pathology (2000) Mentoring and Teaching : He has mentored 8 doctoral students , 7 undergraduates , and 6 postdoctoral fellows , with a focus on diversity. He serves on thesis committees and the URMC MSTP (MD/PhD) admissions committee . Labs and Collaborations : Leads the Morrell Lab at the Aab Cardiovascular Research Institute, collaborating with institutions like Johns Hopkins and Medical College of Wisconsin.

• Platelet Biology
• Vascular Inflammation
• Thrombosis
• +5 more

Dr. Dina Ferdman is an Associate Professor of Pediatrics at Yale School of Medicine, serving as Director of the Pediatric Echocardiogram Program and Co-director of the Yale Fetal Care Center. She practices pediatric cardiology at Yale Pediatric Specialty Centers in Trumbull and Greenwich, providing comprehensive care for congenital heart disease from prenatal diagnosis through adolescence. Education & Training: MD: University of Massachusetts Medical School (2008) Pediatrics Residency: Columbia University Medical Center (2011) Chief Residency: Columbia University Medical Center (2012) Pediatric Cardiology Fellowship: Columbia University Medical Center (2015) Her research focuses on advancing diagnostic techniques in fetal and pediatric cardiology, particularly through echocardiography innovations. She investigates prenatal detection of congenital heart defects, ventricular strain analysis, and quality improvement initiatives for high-risk infant care. Her work integrates clinical practice with translational research to optimize outcomes for children with structural heart disease. Dr. Ferdman's publications demonstrate consistent focus on echocardiography techniques, prenatal diagnosis, and pediatric cardiac management. Recent work explores the application of high-sensitivity biomarkers for myocarditis diagnosis and quality improvement in preventive cardiology. Her longitudinal studies provide valuable insights into cardiac complications of inflammatory conditions like MIS-C. As Co-director of the Yale Fetal Care Center, she leads interdisciplinary teams providing comprehensive care for pregnancies complicated by fetal heart anomalies. She also directs the Pediatric Echocardiogram Program, implementing advanced imaging protocols and quality standards. She contributes to multicenter collaborative studies through the Fetal Heart Society Research Collaborative.

• Congenital Heart Disease
• Fetal Cardiology
• Pediatric Echocardiography
• +4 more

Michael Markl is the Lester B. and Frances T. Knight Professor of Cardiac Imaging and Professor of Biomedical Engineering at Northwestern University's McCormick School of Engineering and Feinberg School of Medicine. His research focuses on developing multi-parametric imaging techniques, particularly 4D Flow MRI, to understand cardiovascular hemodynamics in diseases like heart failure, stroke, and aortic valve disorders. He leads the Markl Lab, advancing applications in clinical diagnostics and therapeutic assessment. Key areas include AI integration for automated analysis, environmental sustainability in MRI, and translational imaging for pediatric and adult cardiovascular conditions. Education: PhD from University of Freiburg (2000). Research emphasizes hemodynamic biomarkers for disease progression, surgical outcomes, and therapy efficacy. Notable contributions include establishing 4D Flow MRI as a standard for aortic valve and pulmonary hypertension evaluation. Scientific Awards: None explicitly listed. Grants and funding details are inferred through lab activities and collaborative initiatives like the Center for Translational Imaging. Advising and Grants: Oversees a multidisciplinary team in the Markl Lab, collaborating on NIH-funded projects and industry partnerships. Focus areas include AI-driven diagnostics, MRI efficiency, and cardiovascular disease modeling. Labs/Teams: Director of the Cardiovascular MRI Group and Co-Director of the Center for Translational Imaging. Active in professional societies like the Society for Cardiovascular Magnetic Resonance (SCMR).

• Cardiac Imaging
• Biomedical Engineering
• Cardiovascular Hemodynamics
• +4 more

Gerard J. Criner, MD , is Chair and Professor of Thoracic Medicine and Surgery at the Lewis Katz School of Medicine, Temple University , and Director of the Temple Lung Center . His clinical and academic work focuses on advanced lung diseases and critical care medicine. Education MD, Lewis Katz School of Medicine at Temple University, Philadelphia, PA Fellowship, Pulmonary and Critical Care Medicine, Boston University School of Medicine, Boston, MA Residency, Internal Medicine, Temple University Hospital, Philadelphia, PA Research Interests Dr. Criner's research centers on advanced lung diseases including COPD, emphysema, pulmonary fibrosis, pulmonary hypertension, and respiratory failure. He is actively involved in clinical trials such as the AIRFLOW-3 and MATINEE studies, exploring innovative treatments for obstructive lung disease and evaluating bronchoscopic lung volume reduction techniques. His work bridges translational research and clinical application in pulmonary medicine and critical care. Recent Publications Trends His editorial contributions to pulmonary and critical care literature highlight his role in medical education and knowledge dissemination, particularly in pathophysiology, mechanical ventilation, and intensive care protocols. Awards and Honors Top Doctors, Pulmonary Disease, Philadelphia magazine (2016–2025) Best Doctors in America®, Pulmonary Medicine & Critical Care Medicine (2015–2020) Professional Service and Advising As Chair and Director, Dr. Criner leads a major academic lung center, overseeing clinical operations, research initiatives, and training programs. He has served as a featured expert in media outlets like 6abc and Medscape, providing commentary on CMS policies and clinical trial findings. His leadership includes mentoring trainees and shaping pulmonary care standards, though specific student advisees are not listed. Labs and Clinical Teams He directs the Temple Lung Center, a multidisciplinary program offering advanced diagnostics and therapies including lung transplantation and bronchoscopic interventions, with locations in Philadelphia and Phoenixville, PA.

• Pulmonology
• Critical Care Medicine
• Chronic Obstructive Pulmonary Disease (COPD)
• +7 more

Hannah Wunsch is a Professor of Anesthesiology at Weill Cornell Medical College , Cornell University. She serves as an Attending Anesthesiologist at NewYork-Presbyterian/Weill Cornell Medical Center. M.D. from Washington University School of Medicine (2003) M.Sc. from London School of Hygiene and Tropical Medicine (2002) A.B. from Harvard University (1997) Her research focuses on critical care medicine , with particular emphasis on sepsis outcomes , mechanical ventilation practices , opioid use in postoperative and ICU settings , and health services research utilizing large administrative datasets. Key trends in her recent publications include ICU staffing models , opioid prescription patterns , mechanical ventilation strategies , and long-term outcomes after critical illness . She has published extensively in top-tier journals like Critical Care Medicine , JAMA , and The Lancet .

• Critical Care Medicine
• Anesthesiology
• Sepsis
• +6 more

John J. Ryan is a Professor of Medicine in the Division of Cardiovascular Medicine at the University of Utah School of Medicine , specializing in General Cardiology and Pulmonary Hypertension . He holds adjunct associate professorships in Family & Preventive Medicine, Orthopaedics, and Radiology & Imaging Sciences. Dr. Ryan’s research focuses on heart failure with preserved ejection fraction , pulmonary vascular disease , and right ventricular function . His work explores statin therapy , microvascular dysfunction , and novel treatments for pulmonary hypertension . His publications emphasize cardiovascular outcomes in pulmonary hypertension, exercise physiology in heart failure, and digital health tools. He is board-certified in Advanced Heart Failure & Transplant Cardiology , Cardiovascular Disease , and Echocardiography . Clinically, he practices at the University of Utah Hospital , with consistently high patient satisfaction scores ( 4.9/5 ). His academic training includes M.D. from University College Cork , followed by residency at Boston Medical Center and fellowships at the University of Chicago Medical Center .

• General Cardiology
• Pulmonary Hypertension
• Heart Failure
• +4 more